Evidence of a phospholipid binding species within human fibrinogen preparations

Thrombosis Research

Volumn 95, Issue 6, 1999, Pages 325-334

  Cunningham, Mark T ^a   Citron, Bruce A ^a   Koerner, Theodore A W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Binding; Fibrinogen; Glycosphingolipid; Light scattering; Phosphatidylserine; Phospholipid

Indexed keywords

CALCIUM CHLORIDE; FIBRINOGEN; PHOSPHOLIPID;

ARTICLE; BINDING KINETICS; FIBRINOGEN METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGHT SCATTERING; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SPECIES DIFFERENCE; TURBIDITY;

FIBRINOGEN; HUMANS; PHOSPHOLIPIDS; PROTEIN BINDING;

EID: 0032845635     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00058-4     Document Type: Article

References (40)

1. Doolittle R.F. Fibrinogen and fibrin. Ann Rev Biochem. 53:1984;195-229.
2. Mosesson M.W. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Sem Hematol. 29:1992;177-188.
3. LeBoef R.D., Gregg R.R., Weigel P.H., Fuller G.M. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry. 26:1987;6052-6057.
4. Galanakis D.K. Anticoagulant albumin fragments that bind to fibrinogen/fibrin. Possible implications Sem Thromb Hemost. 18:1992;44-52.
5. Niewiarowska J., Cierniewski C.S. Inhibitory effect of fibronectin on the fibrin formation. Thromb Res. 27:1982;611-618.
6. Leung L.L.K. Role of thrombospondin in platelet aggregation. J Clin Invest. 74:1984;1764-1772.
7. Galanakis D.K., Ghebrehiwet B. A unique property of plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen. J Clin Invest. 93:1994;303-310.
8. Nesheim M., Wang W., Boffa M., Nagashima M., Morser J., Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost. 78:1997;386-391.
9. Parise L.V., Phillips D.R. Reconstitution of the purified fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex. J Biol Chem. 260:1985;10698-10707.
10. Gunther A.M., Bleyl H., Seeger W. Apoprotein based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro. Am J Physiol. 265:1993;L186-L192.
11. Gunther A.M., Kalinowski A., Elssner A., Seeger W. Clot embedded natural surfactants. Kinetics of fibrinolysis and surface activity Am J Physiol. 265:1994;L618-L624.
12. Gunther A., Kalinowski M., Rosseau S., Seeger W. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. Am J Respir Cell Mol Biol. 13:1995;712-718.
13. Engvall E., Rouslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 20:1977;1-5.
14. Cox A.C., Hanahan D.J. The isolation of undegraded bovine prothrombin and its partial characterization. Biochim Biophys Acta. 207:1970;49-64.
15. Kazal L.A., Amsel S., Miller O.P., Tocantins L.M. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med. 113:1963;989-994.
16. Huang C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry. 8:1969;344-352.
17. Nelsestuen G.L., Lim T.K. Equilibria involved in prothrombin and blood-clotting factor X-membrane binding. Biochemistry. 16:1977;4164-4171.
18. Chen P.S., Toribara T.Y., Warner H. Microdetermination of phosphorus. Anal Chem. 28:1956;1756-1758.
19. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucl Acids Res. 12:1984;387-395.
20. Johnson R.P., Niggli V., Durrer P., Craig S.W. A conserved motif in the tail domain of vinculin mediates association with and insertion into acidic phospholipid bilayers. Biochemistry. 37:1998;10211-10222.
21. Essen L.-O., Perisic O., Cheung R., Katan M., Williams R.L. Crystal structure of a mammalian phosphoinositide-specific phospholipase Cδ Nature. 380:1996;595-602.
22. 2. Biochemistry. 34:1995;5113-5119.
23. Igarashi K., Kaneda M., Yamaji A., Saido T.C., Kikkawa U., Ono Y., Inoue K., Umeda M. A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase. J Biol Chem. 270:1995;29075-29078.
24. Zhou W., Parent L.J., Will J.W., Resh M.D. Identification of a membrane-binding domain within the amino terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol. 68:1994;2556-2569.
25. Leventis R., Silvius J.R. Lipid-binding characteristics of the polybasic carboxy-terminal sequence of K-ras4B. Biochemistry. 37:1998;7640-7648.
26. Henikoff S., Henikoff J.G. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA. 89:1992;10915-10919.
27. Lehmann H.P., Henry J.B. SI units. Henry J.B. Clinical Diagnosis and Management by Laboratory Methods. 1991;1366-1382 W.B. Saunders, Philadelphia, PA.
28. Roberts D.D., Williams S.B., Gralnick H.R., Ginsburg V. von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem. 261:1986;3306-3309.
29. Conforti G., Zanetti A., Pasquali-Ronchetti I., Quaglino D., Neyroz P., Dejna E. Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem. 265:1990;4011-4019.
30. Xu C.J., Nelsestuen G.L. Association of α-phosphatidylinositol-specific-phospholipase c with phospholipid vesicles. Biochim Biophys Acta. 1120:1992;49-58.
31. Koerner T.A.W., Cunningham M.T., Zhang D.-S. The role of membrane lipid in the platelet storage lesion. Blood Cells. 18:1992;481-497.
32. Schroit A.J., Zwaal R.F.A. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta. 1071:1991;313-329.
33. Papahadjopoulos D., Vail W.J., Pangborn W.A., Poste G. Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. Biochim Biophys Acta. 448:1976;265-283.
34. Dang C.V., Shin C.K., Bell W.R., Nagaswami C., Weisel J.W. Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly. J Biol Chem. 264:1989;15104-15108.
35. Rossi J.D., Wallace B.A. Binding of fibronectin to phospholipid vesicles. J Biol Chem. 258:1983;3327-3331.
36. Mann K.G., Lorand L. Introduction. Blood coagulation Methods Enzymol. 222:1993;1-10.
37. Gabriel D.A., Muga K., Boothroyd E.M. The effect of fibrin structure on fibrinolysis. J Biol Chem. 267:1992;24259-24263.
38. Fatah K., Hamsten A., Blomback B., Blomback M. Fibrin network characteristics and coronary artery disease. Relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis Thromb Haemost. 68:1992;130-135.
39. Arocha-Piango C.L., Rodriguez S., Nagy H., Perez Requejo J.L. Fibrinogen Lima. A new dysfibrinogenaemia with high molecular weight alpha-chain and effective polymerization. Blood Coagul Fibrinolysis. 1:1990;561-565.
40. Koopman J., Haverkate F., Grimbergen J., Engesser L., Novakova I., Kerst A.F.J.A., Lord S.T. Abnormal fibrinogen IJmuiden (Bβarg14-cys) and Nijmegen (Bβarg44-cys) form disulfide-linked fibrinogen-albumin complexes. Proc Natl Acad Sci USA. 89:1992;3478-3482.